Fetal Death
12
2
2
4
Key Insights
Highlights
Success Rate
57% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
25.0%
3 terminated out of 12 trials
57.1%
-29.4% vs benchmark
25%
3 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
IntraCERvical Balloon Catheter in the Setting of Induction of Labor for Fetal Loss or Abortion
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
Mifepristone Induction for Fetal Demise
Environmental Factors and Embryonic Development Project
Antenatal Palliative Care
Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies